Healthcare -
Biotechnology - NASDAQ - GB
$ 3.04
3.75 %
$ 470 M
Market Cap
-10.13
P/E
MREO - COST OF REVENUE
Cost of Revenue MREO - Mereo BioPharma Group plc
2.57 M
LAST VALUE
-62.09%
2 YEAR CAGR
-35.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR